ICU Medical ICUI
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
ICU Medical (ICUI) Core Market Data and Business Metrics
Latest Closing Price
$140.38Price-Earnings Ratio
-29.06Total Outstanding Shares
24.52 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
951 Calle Amanecer, San Clemente, CA, 92763-6212
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 325,023 Shares | 2.64 | 3/14/2025 | 858,371 Shares |
| 260,560 Shares | 2.99 | 2/28/2025 | 780,222 Shares |
| 158,346 Shares | 4.97 | 2/14/2025 | 786,379 Shares |
| 228,776 Shares | 3.19 | 1/31/2025 | 729,599 Shares |
| 179,651 Shares | 4.11 | 1/15/2025 | 737,756 Shares |
| 224,463 Shares | 3.73 | 12/31/2024 | 838,137 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-55.80 Million |
| Net Cash Flow From Financing Activities, Continuing | $-55.80 Million |
| Exchange Gains/Losses | $-4.93 Million |
| Net Cash Flow From Operating Activities | $204.03 Million |
| Net Cash Flow From Investing Activities | $-88.96 Million |
| Net Cash Flow, Continuing | $59.27 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Preferred Stock Dividends And Other Adjustments | $0 |
| Nonoperating Income/Loss | $-13.22 Million |
| Interest Expense, Operating | $106.54 Million |
| Basic Average Shares | $24.39 Million |
| Diluted Average Shares | $24.39 Million |
| Operating Income/Loss | $42.96 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-204.01 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-86.32 Million |
| Comprehensive Income/Loss | $-204.01 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $0 |
| Cash | $308.57 Million |
| Current Assets | $1.44 Billion |
| Fixed Assets | $442.75 Million |
| Current Liabilities | $556.18 Million |
| Intangible Assets | $740.79 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||